Healthcare | April 29, 2026
Sanofi Consumer Healthcare reports 33% revenue growth in Q1 FY26; PAT rises 36%
Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market
Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
HCG clinicians contributing to one of the largest bodies of oncology research from India
On segmental performance, API revenues were largely stable at Rs. 454.3 crore for Q3 FY26, down 1% YoY
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Stable profits, low leverage to keep credit profiles comfortable
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The company sees the business reaching $100mn
JB Pharma is the fastest growing pharmaceutical company in FY 2021-22 and Q1 of FY 2022-23.
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
Subscribe To Our Newsletter & Stay Updated
